Compounds > sibutramine
Page last updated: 2024-08-16

sibutramine and mazindol

sibutramine has been researched along with mazindol in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Czupryniak, L; Drzewoski, J1
Arterburn, D2
Arterburn, D; DeLaet, D; Flum, D1
Halpern, A; Mancini, MC1
Fujioka, M; Mikami, E; Miyamoto, K; Sumioka, S; Yamamoto, S1
Boguszewski, CL; Cunha, DR; do Desterro de Figueiredo, M; dos Santos, CM; Radominski, R; Suplicy, H1
Correr, CJ; Fernandez-Llimos, F; Lucchetta, RC; Otuki, MF; Pontarolo, R; Radominski, RB; Riveros, BS1

Reviews

4 review(s) available for sibutramine and mazindol

ArticleYear
Obesity.
    Clinical evidence, 2003, Issue:10

    Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine; Phenylpropanolamine

2003
Obesity.
    Clinical evidence, 2004, Issue:11

    Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine; Phenylpropanolamine; Selective Serotonin Reuptake Inhibitors

2004
Obesity.
    Clinical evidence, 2005, Issue:13

    Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Gastric Bypass; Gastroplasty; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine

2005
Pharmacological treatment of obesity.
    Arquivos brasileiros de endocrinologia e metabologia, 2006, Volume: 50, Issue:2

    Topics: Amphetamines; Anti-Obesity Agents; Appetite Depressants; Clinical Trials as Topic; Cyclobutanes; Energy Metabolism; Homeostasis; Humans; Lactones; Mazindol; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Weight Loss

2006

Trials

1 trial(s) available for sibutramine and mazindol

ArticleYear
A comparative study of five centrally acting drugs on the pharmacological treatment of obesity.
    International journal of obesity (2005), 2014, Volume: 38, Issue:8

    Topics: Adult; Amphetamines; Anti-Obesity Agents; Body Mass Index; Brazil; Cyclobutanes; Diet, Reducing; Diethylpropion; Female; Fluoxetine; Follow-Up Studies; Humans; Mazindol; Obesity; Prospective Studies; Surveys and Questionnaires; Treatment Outcome; Weight Loss

2014

Other Studies

4 other study(ies) available for sibutramine and mazindol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
[The role of pharmacotherapy for treatment of obesity in adults].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2000, Volume: 9, Issue:53

    Topics: Adult; Animals; Anti-Obesity Agents; Chlorphentermine; Cyclobutanes; Dexfenfluramine; Dopamine Agonists; Ephedrine; Fluoxetine; Humans; Lactones; Mazindol; Obesity; Orlistat

2000
Study on detection of drugs in slimming health foods using GC-MS/MS.
    Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan, 2011, Volume: 52, Issue:6

    Topics: Cyclobutanes; Drug Approval; Fenfluramine; Food, Organic; Gas Chromatography-Mass Spectrometry; Legislation, Drug; Mazindol; Phenolphthalein; Tandem Mass Spectrometry

2011
Diethylpropion and mazindol: An end to the discussion?
    Revista da Associacao Medica Brasileira (1992), 2017, Volume: 63, Issue:3

    Topics: Amphetamines; Appetite Depressants; Brazil; Cyclobutanes; Diethylpropion; Drug Approval; Humans; Mazindol; Obesity; Risk Assessment; Treatment Outcome

2017